Training future experts in pediatric and maternal-fetal clinical pharmacology
Official title: Clinical Pharmacology Training Program
Funded at Thomas Jefferson University · NIH-11095275 · Data updated 2026-11-12
This program is designed to help new doctors learn how to develop safe and effective medications for children and pregnant women, giving them the skills they need to make a difference in healthcare.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | May 21, 2025 |
| Project end | April 30, 2030 |
| Funding year | 2025 |
| Award (this year) | $211,465 |
| NIH project number | 1T32HD117733-01 |
| Project ID | NIH-11095275 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this program are postdoctoral fellows, including MDs, MD-PhDs, PharmDs, and PhDs interested in clinical pharmacology.
✕Less likely to help
Patients who are not involved in academic or clinical research training may not receive direct benefits from this program.
What this research studies
This program focuses on training postdoctoral fellows in pediatric and maternal-fetal clinical pharmacology at Children's Hospital of Philadelphia and Thomas Jefferson University. It aims to prepare participants for careers in drug development through a combination of coursework, conferences, and hands-on research. Trainees will engage in hypothesis-driven research that explores drug discovery, development, and safety, ensuring they are equipped to address the evolving needs in therapeutics. The program emphasizes a collaborative environment to foster innovation in disease management.
Why it matters
Potential benefit: If successful, this research could lead to improved drug therapies specifically tailored for pediatric and maternal-fetal populations.
How similar studies have gone: Similar training programs have successfully produced skilled professionals in clinical pharmacology, contributing to advancements in drug development.
Where this research is happening
-
Thomas Jefferson University
Philadelphia, United States Active
Researchers
- Principal investigator: Kraft, Walter K — Thomas Jefferson University
- Study coordinator: Kraft, Walter K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.